• / Free eNewsletters & Magazine
  • / My Account
Home>Clinigen Group Buys Oncology Support Therapy from AstraZeneca

Clinigen Group Buys Oncology Support Therapy from AstraZeneca

3party Content

Wed, 20 Aug 2014

By Jana Simmons LONDON--Clinigen Group PLC (CLIN.LN), a pharmaceutical company, on Wednesday said it has bought the global rights to oncology support therapy Ethyol (amifostine) from AstraZeneca PLC (AZN.LN) for an undisclosed sum. Ethyol is being used to reduce xerostomia, or dry mouth, as a
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.